Biotech Investors & VC Firms in Asia-Pacific

571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Aescuvest 1 person · Leads rounds	Frankfurt am Main	DE	Seed–Late Stage	—	+ Add to CRM
Elmirate Capital Leads rounds	Dubai	AE	Seed–Late Stage	$1M – $250M	+ Add to CRM
Oscar & Paul Beiersdorf Venture Capital Follows rounds	Hamburg	DE	Seed–Growth	$580K – $5.8M	+ Add to CRM
TCG Labs 2 people	San Francisco	US	—	—	+ Add to CRM
Trans-it Capital 1 person	Palo Alto	US	Seed	—	+ Add to CRM
Camford Capital 8 people	Menlo Park	US	Pre-Seed–Series A	—	+ Add to CRM
CARELA Holding GmbH	Hamburg	DE	—	—	+ Add to CRM
A. M. Pappas & Associates 1 person	Durham	US	Pre-Seed–Series A	—	+ Add to CRM
Bioscience Equity Partners 1 person	Dubai	AE	Late Stage	—	+ Add to CRM
Unveil Pharma 1 person	Boston	US	Pre-Seed–Series A	—	+ Add to CRM
Biomark Capital 4 people	Greenwich	US	Series A–Late Stage	$5M – $10M	+ Add to CRM
Worthwhile Industries Campuses	Toronto	CA	Late Stage	—	+ Add to CRM
RMGP Biopharma Investment Fund 6 people	Herzliya	IL	Seed–Series A	—	+ Add to CRM
Ela Capital	Toronto	CA	Pre-Seed–Growth	—	+ Add to CRM
Dow Venture Capital 1 person	Midland	US	Seed–Series A	$250K – $5M	+ Add to CRM
10x Genomics 4 people	Pleasanton	US	—	—	+ Add to CRM
ePlanet Capital 3 people	San Jose	US	Seed–Late Stage	—	+ Add to CRM
ShangPharma Innovation 2 people	South San Francisco	US	Seed–Series A	—	+ Add to CRM
HSBC Innovation Ventures 1 person	London	GB	Seed–Growth	—	+ Add to CRM